Furthermore, a knock-down of TAP-1 gene or epigenetic changes and TAP-1 protein downregulation, as well as the loss of tapasin, an essential component of the peptide-loading complex (PLC) in human cancer cells, elicits tumour immune escape by inhibiting CTL surveillance against the tumour. The gene discussed is TAP1; the disease is neoplasm.